Prognostic value of cyclin B in endometrial endometrioid adenocarcinoma. (Q50622995)

16 March 2018

title

Prognostic value of cyclin B in endometrial endometrioid adenocarcinoma. (English)

1 reference

16 March 2018

1 reference

3

Ylermi Soini

1 reference

16 March 2018

Simi Santala

1

1 reference

16 March 2018

Anne Talvensaari-Mattila

series ordinal

2

1 reference

16 March 2018

Markku Santala

series ordinal

4

1 reference

16 March 2018

publication date

15 October 2014

1 reference

16 March 2018

published in

Tumor Biology

1 reference

16 March 2018

volume

36

1 reference

16 March 2018

issue

2

1 reference

16 March 2018

page(s)

953-957

1 reference

16 March 2018

https://scigraph.springernature.com/pub.10.1007/s13277-014-2676-4

exact match

0 references

cites work

Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Revised FIGO staging for carcinoma of the endometrium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Tissue and serum biomarkers as prognostic variables in endometrioid-type endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Cell cycle control across the eukaryotic kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Cell cycle, CDKs and cancer: a changing paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

High cyclin B1 expression is associated with poor survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Progressive derailment of cell cycle regulators in endometrial carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Expression of cell-cycle regulatory proteins in endometrial carcinomas: correlations with hormone receptor status and clinicopathologic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Expression of cyclin H in normal and cancerous endometrium, its correlation with other cyclins, and association with clinicopathologic parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Cell cycle regulators and apoptosis-associated proteins in relation to proliferative activity and degree of apoptosis in HNPCC versus sporadic endometrial carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Cyclin A in cell cycle control and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

The impact of cyclin D1 overexpression on the prognosis of ER-positive breast cancers: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Meta-analysis for cyclin E in lung cancer survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Prognostic significance of ATM and cyclin B1 in pancreatic neuroendocrine tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

High expression of cyclin A is associated with poor prognosis in endometrial endometrioid adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Secondary analyses from a randomized clinical trial: age as the key prognostic factor in endometrial carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-2676-4

Cyclin B1 is a prognostic proliferation marker with a high reproducibility in a population-based lymph node negative breast cancer cohort

21 January 2018

1 reference

12 December 2020

Expression and prognostic significance of cyclin B1 and cyclin A in non-small cell lung cancer

1 reference

12 December 2020

The impact of surgery on survival of elderly women with endometrial cancer in the SEER program from 1992-2002

1 reference

12 December 2020

Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus

1 reference

12 December 2020

Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma

1 reference

12 December 2020

From Cdc2 to Cdk1: when did the cell cycle kinase join its cyclin partner?

1 reference

12 December 2020

Immunohistochemical expression of cyclins, cyclin-dependent kinases, tumor-suppressor gene products, Ki-67, and sex steroid receptors in endometrial carcinoma: positive staining for cyclin A as a poor prognostic indicator

1 reference

12 December 2020

10.1007/S13277-014-2676-4

Identifiers

DOI

1 reference

16 March 2018

PubMed ID

25315186

1 reference

16 March 2018